Global LDL Test Market Size, Share, Forecast Report, 2020-2027

LDL is also mentioned as bad cholesterol since high levels of LDL results in cholesterol build-up which may lead to heart attack and strokes. LDL is one of the five major types of lipoproteins and other four are chylomicrons, very low-density lipoprotein (VLDL), intermediate-density lipoprotein (IDL), low-density lipoprotein (LDL) and high-density lipoprotein (HDL). The major role of lipoprotein particles is to transport fats such as triglycerides and cholesterol in the blood between the organs of the body.

According to Centres for Disease Control and Prevention, (2015) 71 million American adults have high low-density lipoprotein (LDL), or bad cholesterol level. Only 2 out of every 3 adults with LDL cholesterol has the condition under control.

The market drivers for LDL market are increasing geriatric population, increasing obese and overweight population. The major market restraints for this test are risks associated with this such as excessive bleeding and infection during multiple puncture wounds, low healthcare expenditure in developing regions which may hamper the market growth.
Segments:
The global LDL test market has been segmented on the basis of types, components, applications and end users.

Based on types, the market has been segmented into LDL-C, LDL-P, LDL-B and others.

Based on components, the market has been segmented into devices, kits & reagents and others. Devices is further sub-segmented into syringes & needles, spectrophotometers and others. And kits & reagents is further sub-segmented into toxicity assays kit, blood chemistry assays kit, cytotoxicity assays kit.

Based on application, the market has been segmented as atherosclerosis, obesity, dyslipidemia, diabetes, angina, stroke, carotid artery disease, peripheral arterial disease, others.

Based on the end users, the market has been segmented as hospitals and clinics, pharmaceutical and biotechnological companies and others.